CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
10 research outputs found
Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine
Author
Bexsero
Centers for Disease Control and Prevention
Maslanka SE
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease
Author
Bexsero® (Meningococcal group B vaccine)
Cohn AC
Trumenba® (meningococcal group B vaccine)
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak
Author
Bexsero (Meningococcal Group B Vaccine)
Bilukha OO
+5 more
Folaranmi T
Garon D
Hess D
Soeters HM
Trumenba (meningococcal group B vaccine)
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcal vaccine recommendations
Author
Bart SM
Bexsero (meningococcal group B vaccine)
+10 more
Bexsero® (Meningococcal Group B Vaccine)
Bilukha OO
Burman C
Carr W.
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Cohn AC
Menveo® (Meningococcal [Groups A C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine)
Srivastava A
Trumenba® (meningococcal group B vaccine)
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
A physician’s guide to the 2-dose schedule of MenB-FHbp vaccine
Author
Basta N
Bexsero (meningococcal group B vaccine)
+9 more
California Health Alert Network San Diego
Cohn AC
De Maria A
Folaranmi T
Huang L
Menactra® (meningococcal [groups A C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine)
Menveo® (meningococcal [groups A C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine)
NIMENRIX (meningococcal polysaccharide serogroups A C, W-135 and Y conjugate vaccine)
Trumenba® (meningococcal group B vaccine)
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB‐FHbp
Author
Ahmed F
Bexsero (4CMenB)
+13 more
Bilukha OO
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Cohn AC
Folaranmi T
Mbaeyi SA
Menactra® (meningococcal [groups A C, Y and W‐135] polysaccharide diphtheria toxoid conjugate vaccine)
Menveo® (meningococcal [groups A C, Y and W‐135] oligosaccharide diphtheria CRM197 conjugate vaccine)
Muse D
National Center for Immunization and Respiratory Diseases
Pfizer Canada Inc
Trumenba® (Meningococcal group B vaccine)
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
Author
Bexsero (Meningococcal group B Vaccine [rDNA component, adsorbed])
Cohn AC
+16 more
Deghmane A
Diana A
Knol MJ
MENHIBRIX (Hib-MenCY-TT)
Meningitec (meningococcal serogroup C conjugate vaccine)
MenQuadfi (MenACWY-TT)
Menveo (Meningococcal Group A C, W135 and Y conjugate vaccine)
Ministero della Salute Italia
NeisVac-C (Meningococcal Group C Polysaccharide Conjugate Vaccine Adsorbed)
New Zealand Ministry of Health
NIMENRIX
Reinsert Skoczynska A Wasko I, Kuch A, Ronkiewicz P, Golebiewska A, Wrobel I, Kiedrowska M, Hryniewicz W
Skoczynska A
Trumenba (MenB-FHbp)
Villena R
Wasko I
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
Author
Angela Quinn
Australian Government Department of Health
+41 more
Azzari
BEXSERO (meningococcal group B vaccine)
Bhuyan
Centers for Disease Control and Prevention
Cohn
Cohn
EU-IBIS Network
European Centre for Disease Prevention and Control
European Medicines Agency
Finne
Fletcher
Folaranmi
Giuliani
Gregg H. Lucksinger
HAVRIX (hepatitis A vaccine)
Health Canada
Jackson
Jiang
Johannes Beeslaar
John L. Perez
Joseph Eiden
Judith Absalon
Kathrin U. Jansen
Kohl
Lars Ostergaard
Laura J. York
Marshall
Marshall
Martinon-Torres
Masignani
Mette E. Graversen
Nissen
Pace
Public Health England
Richmond
Richmond
Sheldon
Stephens
Thigpen
Vesikari
Wang
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence
Author
Bexsero® (Meningococcal group B vaccine)
Bilukha OO
+17 more
Cohn AC
Folaranmi T
Gardasil (human papillomavirus quadrivalent (types 6 11, 16, and 18) vaccine, recombinant)
Immunization of adolescents
Keiser P
Menactra® (MCV4)
MenAfriVac (meningococcal A conjugate vaccine)
MENHIBRIX® (Hib-MenCY-TT)
Meningitec (meningococcal serogroup c conjugate vaccine)
Menitorix (Haemophilus type b and meningococcal group C conjugate vaccine)
Menjugate 10 micrograms suspension for injection (meningococcal group C conjugate vaccine)
Menveo® (Meningococcal [Groups A C, Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine)
National Center for Immunization and Respiratory Diseases
NeisVac-C (meningococcal C conjugate vaccine)
Pfizer Canada Inc
Stokley S
Trumenba®
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines
Author
Bexsero® (MenB-4C)
Bilukha OO
+15 more
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Keiser PB
Maslanka SE
Menactra® (meningococcal [groups A C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine)
Menitorix (Haemophilus type B and meningococcal group C conjugate vaccine)
Menjugate 10 micrograms suspension for injection (meningococcal group C conjugate vaccine)
Menveo® (meningococcal [groups A C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine)
Milagres LG
NeisVac-C (meningococcal C conjugate vaccine)
Nimenrix (meningococcal group A C, W-135 and Y conjugate vaccine)
Trumenba® (meningococcal group B vaccine)
World Health Organization
World Health Organization
Zollinger WD
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref